IDH1-MUTATED MALIGNANCIES
Clinical trials for IDH1-MUTATED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new IDH1-MUTATED MALIGNANCIES trials appear
Sign up with your email to follow new studies for IDH1-MUTATED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study checks cancer drug safety for patients with organ issues
Disease control Recruiting nowThis study tests the safety and how the body processes the drug ivosidenib in 30 adults with IDH1-mutated cancers who also have liver or kidney problems. Participants take the drug by mouth and have regular checkups including blood tests and heart monitoring. The goal is to find …
Matched conditions: IDH1-MUTATED MALIGNANCIES
Phase: PHASE1 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
New combo therapy targets tough blood cancers
Disease control Recruiting nowThis study is for adults with blood cancers that have returned or not responded to treatment and have specific gene changes (IDH1 and another signaling mutation). The purpose is to see if combining the drug olutasidenib with other targeted therapies is safe and tolerable. About 6…
Matched conditions: IDH1-MUTATED MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC